Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. Gate2Brain pursues its goals using a radically innovative peptide-based patented technology platform.
G2B-002, Gate2Brain flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare paediatric cancers.
Company Details
- Employees
- 13
- Founded
- -
- Address
- Parc Científic De Barcelona, Baldiri Reixac 4-8, Torre I, Barcelona,08028,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- gate2brain.com
- Keywords
- Drug development, Pediatric solid tumors, Peptide shuttles, Brain delivery, Skin delivery, DIPG, Rare diseases, Central nervous system, Drug transport, Orphan drug.
- HQ
- Barcelona
Gate2brain Questions
Gate2Brain's website is gate2brain.com
Gate2Brain's LinkedIn profile is https://es.linkedin.com/company/gate2brain
Gate2Brain has
13 employees.
View email and phone details for 13
employees at Gate2Brain.
Gate2Brain's industry is
Biotechnology Research
Gate2Brain's top competitors are
Pulmobiotics Sl,
Lumatix Biotech,
Incapto,
Trak,
Oniria Therapeutics,
Theker Robotics,
Trioteca,
Succipro,
Optieum Biotechnologies Inc.,
Affirma Biotech Sl.
Gate2Brain's categories are Biotechnology Research
Gate2Brain's founding year is 2020
